COMMUNIQUÉS West-GlobeNewswire
-
First-half 2026 results
29/07/2026 -
F6S Ranks Life Backup Plan 55th in Health and Wellness
29/07/2026 -
CorVascular to Showcase DuplexABI™ Solution at SVU 2026 Annual Conference & Marketplace
29/07/2026 -
Ipsen nomme Catherine Bradley en tant que nouvelle administratrice indépendante au sein de son Conseil d’administration
29/07/2026 -
Résultats semestriels 2026
29/07/2026 -
First-Half 2026 results confirm commercial and operational resilience in a challenging market environment - Transformation progressing as planned, including the divestment of the Brindisi site
29/07/2026 -
New Research using Clue Data Suggests Menstrual Cycle Timing May Influence Vaccine Side Effects
29/07/2026 -
EssilorLuxottica: Mise à disposition du Rapport financier semestriel 2026
29/07/2026 -
As Indiana's Nurse Shortage Grows, Jersey College and Lutheran Hospital Mark Five Years of Solving It Together
29/07/2026 -
EssilorLuxottica: Publication of the 2026 Interim Financial Report
29/07/2026 -
SOUND Behavioral Health Launches Corporate Community Partner Program During 60th Anniversary Year
29/07/2026 -
As New Research Shows Long Covid Affects 1 in 6 Patients, Apheresis Center Analysis Finds US Insurance Policies Are Driving Patients Abroad.
29/07/2026 -
Ipsen nominates Catherine Bradley to its Board of Directors as independent Director
29/07/2026 -
Les résultats du premier semestre 2026 confirment la résilience commerciale et opérationnelle dans un environnement de marché difficile - La transformation progresse selon le calendrier avec notamment la cession du site de Brindisi
29/07/2026 -
Angelman Syndrome Foundation and Citizen Health Partner to Put Advanced AI to Work for Every Angelman Family
29/07/2026 -
Rose Hill Life Sciences Appoints Bryan Smith as Scientific Advisor
29/07/2026 -
HeartSciences Files Preliminary Proxy Statement for Business Combination with Fortitude Mining Holdings; Provides Business Update and Reports Fiscal 2026 Financial Results
29/07/2026 -
HCW Biologics Inc. Announces Pricing of $1.6 Million Private Placement Offering
29/07/2026 -
SciSparc: Subsidiary NeuroThera Labs Advances its Quantum Platform for Clinical Data Analytics on a Platform of an S&P 500 company
29/07/2026
Pages